![]() Of these, 54 had a new active substance which had never been authorised in the EU before. EMA recommended 92 human medicines for marketing authorisation in 2021. The report also showcases how EMA continued to address public and animal health needs beyond the pandemic. An overview of the Agency’s activities to prepare for its new legal mandate is provided in the report. In future, EMA will also closely monitor and mitigate shortages of medicines and medical devices during major events and public health emergencies and facilitate faster approval of medicines for the treatment or prevention of diseases causing a public health crisis. In light of the experience accrued by EMA while dealing with the public health crisis, EU institutions took first steps towards extending EMA’s role in crisis preparedness and management of medicinal products and medical devices. In addition, the annual report highlights key lessons learnt during the public health crisis. The Agency was also successful in supporting the scaling up of vaccine manufacturing capacity that led to a substantial increase in vaccine supply in the EU and globally. EMA recommended four vaccines and five treatments for COVID-19 for marketing authorisation in the EU. The efficient and timely response to the COVID-19 pandemic remained the number one priority for EMA and the European medicines regulatory network in 2021. It also contains an interactive timeline of important milestones in 2021, allowing readers to explore each topic in more depth through additional documents, audio-visual materials and infographics. The digital report features main outcomes regarding the evaluation and monitoring of human and veterinary medicines and the European medicines regulatory network’s response to COVID-19, and includes a selection of key figures. These include the Agency’s activities to tackle the COVID-19 pandemic but also its work related to the scientific assessment and supervision of medicines in the EU. The Gameface IP catalog will accompany Adler in moving to Potato, where it will integrate with Potato’s existing content lineup.EMA’s annual report 2021 published today provides an overview of the Agency’s activities to protect and promote public and animal health in the European Union (EU) and highlights EMA’s most significant achievements. Adler joins Potato from Gameface, another ITV Studios label responsible for programs such as “The Void” and “Britain’s Brightest Family” among others. The hire is part of the Potato’s move to increase its focus on quiz and game shows. *****Īdam Adler, creator of the global hit platform “ The Cube,” is joining U.K.-based ITV Studios label Potato as creative director, reporting to Potato managing director Michael Kelpie. Wood will lead BFI audience development strategies via public programs and education initiatives, held in-person and online across the U.K. Oke will join the BFI in January and head teams at the BFI National Archive and BFI Reuben Library while leading strategic support for the U.K.’s screen heritage sector. Both appointments were made by BFI chief executive Ben Roberts, who will work closely with Oke and Wood on creating and developing a new ten-year strategic vision at the BFI. In a pair of high-profile moves, the BFI has appointed Arike Oke as executive director of knowledge and collections and Jason Wood as executive director of public programs and audiences.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |